Documentos de Valenzuela-Silva C.M. | REDI

Regresar

Mostrando 2 resultados de: 2

Filtros aplicados

Palabras Claves: "Itolizumab"

Subtipo de publicación

Publisher

Clinical and Translational Immunology(1)

Immunity and Ageing(1)

Área temáticas

Enfermedades(2)

Microorganismos, hongos y algas(2)

Farmacología y terapéutica(1)

Área de conocimiento

Inmunología(2)

Año de Publicación

Origen

Palabras Claves

Cytokine release syndrome(2)

Monoclonal antibody(1)

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

Abstract: Background: Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the

Palabras claves:

covid-19, Cytokine release syndrome, IL-6, Itolizumab

Añe-Kouri A.L., Betancourt J., Caballero A., Cepeda M., Chávez E., Filgueira L.M., Herrera C., Hidalgo C.J., Leon K., Lorenzo G., Manso L., Mazorra Z., Ramos M., Saavedra Hernández D., Sánchez N., Tania Crombet, Valenzuela-Silva C.M.

Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab

Abstract: Objectives: COVID-19 can lead to a hyperinflammatory state. CD6 is a glycoprotein expressed on matur

Palabras claves:

CD6, covid-19, Cytokine release syndrome, Itolizumab, Monoclonal antibody, SARS-COV2

Arencibia M., Betancourt J., Caballero A., Cabrera L., Castillo U., Cepeda M., Despaigne R.E., Diaz H., Domecq M., Escalona A., Estevez D., Filgueira L.M., García Y., Hidalgo C.J., Leon K., Lorenzo G., Lorenzo P., Martinez A., Mazorra Z., Meriño E., Ortega L.M., Ramírez A., Ramos M., Saavedra Hernández D., Sánchez L., Sánchez N., Tania Crombet, Valenzuela-Silva C.M.